As compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cancer Master Protocol (Lung-MAP) has enrolled higher percentages of patients who are older, patients who are from rural or socioeconomically deprived areas, and patients who have Medicaid or no insurance.

Related Keywords

Oregon , United States , Staceyj Adam , Karen Kelly , Michaell Leblanc , Roys Herbst , Riha Vaidya , Ellenv Sigal , Jhanellee Gray , Maryw Redman , Katherine Minichiello , Davidr Gandara , Martinj Edelman , Josephm Unger , Lu Qian , Shakun Malik , Konstantinh Dragnev , Joelw Neal , Jyotid Patel , Saiaman Waqar , Charlesd Blanke , Foundation Medicine , Dartmouth Cancer Center , Uc Davis Comprehensive Cancer Center , Emory University , Science University , Amgen , Bristol Myers Squibb , Community Oncology Research Program , Genentech , Astrazeneca , Twitter , Yale Cancer Center , National Clinical Trials Network , National Cancer Institute Clinical Trials Network , National Institutes Of Health , Foundation For The National Institutes Of Health , Moffitt Cancer Center , Washington University School Of Medicine , Pfizer , Stanford Cancer Institute , Fred Hutchinson Cancer Center , Cancer Research Network , Northwestern University Feinberg School Of Medicine , Fox Chase Cancer Center , Winship Cancer Institute , Oregon Health , Friends Of Cancer Research , Method Of Research , Temple University Health System , National Cancer Institute , Data Management Center , Lung Cancer Master Protocol , National Clinical Trials , National Institutes , Research Network , Cancer Research , Area Deprivation Index , Comprehensive Cancer Center , Northwestern University Feinberg School , Washington University School , Fred Hutchinson Cancer , Patients Enrolled , Oncology Research Program ,